| Old Articles: <Older 6621-6630 Newer> |
|---|
 |
The Motley Fool
August 26, 2010
Rich Smith |
This Just In: Upgrades and Downgrades Deutsche Securities took the bull side of Wall Street's bearish, anti-medical devices trade, initiating coverage of diagnostic equipment maker China Medical Technologies and reinitiating coverage of Mindray Medical, both with buys.   |
The Motley Fool
August 26, 2010
Travers & Jayson |
Will Onyx Pharmaceuticals Burn You? Is Onyx Pharmaceuticals on strong financial footing? |
The Motley Fool
August 26, 2010
Jordan DiPietro |
Pfizer's Dividends May Not Last Forever Pfizer, which operates in the pharmaceuticals industry, currently pays a dividend of 4.5%. But what's more important than the dividend itself is Pfizer's ability to keep that that cash rolling. |
InternetNews
August 25, 2010 |
Security, EMRs Top Healthcare IT Priorities With new government regulations placing even more responsibility and scrutiny on the healthcare industry, IT administrators are struggling to deliver both efficiency and security. |
The Motley Fool
August 25, 2010
Brian Orelli |
Shares Soar! That'll Help Investors Sleep Better Tonight. Somaxon finds a marketing partner for its insomnia drug. |
The Motley Fool
August 25, 2010
David Meier |
Could Medtronic Be a Multibagger? With higher margins than ZOLL Medical and Boston Scientific, Medtronic clearly outshines the competition. |
The Motley Fool
August 25, 2010
David Meier |
Can MedcoHealth Solutions Produce Big Returns? MedcoHealth Solutions generates incredible returns on equity. Let's see how it does it. |
The Motley Fool
August 25, 2010
Jeremy Phillips |
Time to Short Medifast? Medifast has a current short interest of 18.80%. That's pretty high, but let's see how it compares to other companies selling health enhancement products. |
The Motley Fool
August 24, 2010
Dan Dzombak |
The 15 Highest-Yielding Health-Care Equipment Stocks These fat yields may not be as promising as they seem. |
The Motley Fool
August 24, 2010
David Meier |
Could Alcon Be a Multibagger? Strong returns on equity can generate powerful shareholder returns. |
| <Older 6621-6630 Newer> Return to current articles. |
